N🟁N

Finkelstein Thompson LLP Announces Investigation of CPI International, Inc.

  //science-technology.news-articles.net/content/2 .. nces-investigation-of-cpi-international-inc.html
  Published in Science and Technology on Tuesday, November 30th 2010 at 16:10 GMT by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

WASHINGTON--([ BUSINESS WIRE ])--Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of CPI International, Inc. (aCPIa or the aCompanya) (NASDAQ: CPII) concerning the proposed acquisition of the Company by Veritas Capital. Under the terms of the offer, CPI shareholders will receive $19.50 in cash for each share of the Companya™s common stock held in a transaction valued at approximately $525 million, including debt assumption.

The investigation is focused on the potential unfairness of the deal price to CPI shareholders, the process by which the CPI Board of Directors considered the transaction, and potential conflicts of interests on the part of CPI Board members. Certain CPI shareholders have already entered into a voting agreement with an affiliate of Veritas Capital to vote approximately 49 percent of the Companya™s outstanding shares in favor of the merger.

If you are interested in discussing your rights as a CPI shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at [ contact@finkelsteinthompson.com ].

Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers.

To learn more about Finkelstein Thompson LLP, please visit our web site at [ www.finkelsteinthompson.com ]. Attorney advertising. Prior results do not guarantee similar outcomes.